Literature DB >> 30228705

Imaging in Prostate Cancer: Magnetic Resonance Imaging and Beyond.

Daniel R Ludwig1, Tyler J Fraum2, Kathryn J Fowler3, Joseph E Ippolito4.   

Abstract

Imaging is becoming critical for guiding management decisions in prostate cancer (PCa) both at initial diagnosis and at recurrence. Multiparametric magnetic resonance imaging (mpMRI) and positron emission tomography (PET) of the prostate have proven valuable in the detection and localization of aggressive disease. Therefore, understanding the indications for mpMRI, imaging techniques and interpretation, limitations of current imaging approaches, and utility of PET and simultaneous PET/MRI has become increasingly important.

Entities:  

Mesh：

Year:  2018        PMID： 30228705      PMCID： PMC6139856     

Source DB:  PubMed          Journal:  Mo Med        ISSN： 0026-6620


  20 in total

Review 1.  Pictorial review. Diagnosis of recurrent prostate cancer and its mimics at multiparametric prostate MRI.

Authors:  Mark Notley; Jinxing Yu; Ann S Fulcher; Mary Ann Turner; Charles H Cockrell; Don Nguyen
Journal:  Br J Radiol       Date:  2015-08-13       Impact factor: 3.039

2.  Proposed Adjustments to PI-RADS Version 2 Decision Rules: Impact on Prostate Cancer Detection.

Authors:  Andrew B Rosenkrantz; James S Babb; Samir S Taneja; Justin M Ream
Journal:  Radiology       Date:  2016-10-26       Impact factor: 11.105

3.  Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.

Authors:  Simpa S Salami; Eran Ben-Levi; Oksana Yaskiv; Baris Turkbey; Robert Villani; Ardeshir R Rastinehad
Journal:  J Magn Reson Imaging       Date:  2016-07-13       Impact factor: 4.813

4.  Diagnostic value of integrated PET/MRI for detection and localization of prostate cancer: Comparative study of multiparametric MRI and PET/CT.

Authors:  Myoung Seok Lee; Jeong Yeon Cho; Sang Youn Kim; Gi Jeong Cheon; Min Hoan Moon; Sohee Oh; Joongyub Lee; Seunghyun Lee; Sungmin Woo; Seung Hyup Kim
Journal:  J Magn Reson Imaging       Date:  2016-09-01       Impact factor: 4.813

5.  Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI.

Authors:  Martin T Freitag; Jan P Radtke; Ali Afshar-Oromieh; Matthias C Roethke; Boris A Hadaschik; Martin Gleave; David Bonekamp; Klaus Kopka; Matthias Eder; Thorsten Heusser; Marc Kachelriess; Kathrin Wieczorek; Christos Sachpekidis; Paul Flechsig; Frederik Giesel; Markus Hohenfellner; Uwe Haberkorn; Heinz-Peter Schlemmer; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-17       Impact factor: 9.236

6.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading.

Authors:  Adil Ouzzane; Philippe Puech; Laurent Lemaitre; Xavier Leroy; Pierre Nevoux; Nacim Betrouni; Georges-Pascal Haber; Arnauld Villers
Journal:  Urology       Date:  2011-08-16       Impact factor: 2.649

Review 7.  Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.

Authors:  Ivo G Schoots; Monique J Roobol; Daan Nieboer; Chris H Bangma; Ewout W Steyerberg; M G Myriam Hunink
Journal:  Eur Urol       Date:  2014-12-03       Impact factor: 20.096

8.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.

Authors:  James S Wysock; Andrew B Rosenkrantz; William C Huang; Michael D Stifelman; Herbert Lepor; Fang-Ming Deng; Jonathan Melamed; Samir S Taneja
Journal:  Eur Urol       Date:  2013-11-08       Impact factor: 20.096

Review 9.  Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review.

Authors:  M A Haider; X Yao; A Loblaw; A Finelli
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-05-30       Impact factor: 4.126

10.  Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.

Authors:  Markus Dietlein; Carsten Kobe; Georg Kuhnert; Simone Stockter; Thomas Fischer; Klaus Schomäcker; Matthias Schmidt; Felix Dietlein; Boris D Zlatopolskiy; Philipp Krapf; Raphael Richarz; Stephan Neubauer; Alexander Drzezga; Bernd Neumaier
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.